Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash & Equivalents (2021 - 2025)

Biote has reported Cash & Equivalents over the past 5 years, most recently at $24.1 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $24.1 million for Q4 2025, down 38.68% from a year ago — trailing twelve months through Dec 2025 was $24.1 million (down 38.68% YoY), and the annual figure for FY2025 was $24.1 million, down 38.68%.
  • Cash & Equivalents for Q4 2025 was $24.1 million at Biote, down from $28.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BTMD hit a ceiling of $89.0 million in Q4 2023 and a floor of $19.6 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $39.3 million (2024), compared with a mean of $49.8 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 265.57% in 2022 and later crashed 61.42% in 2024.
  • Biote's Cash & Equivalents stood at $26.8 million in 2021, then skyrocketed by 196.01% to $79.2 million in 2022, then grew by 12.33% to $89.0 million in 2023, then tumbled by 55.8% to $39.3 million in 2024, then tumbled by 38.68% to $24.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $24.1 million (Q4 2025), $28.0 million (Q3 2025), and $19.6 million (Q2 2025) per Business Quant data.